Point72 Middle East FZE’s Nektar Therapeutics NKTR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-9,143	Closed	-$78.9K	–	1231
2023 Q2	$78.9K	Buy	+9,143	New	+$78.9K	﹤0.01%	720
2023 Q1	–	Sell	-2,272	Closed	-$77K	–	1459
2022 Q4	$77K	Buy	+2,272	New	+$77K	﹤0.01%	823